The prevention of stroke is a primary goal in patients with atrial fibrillation (AF) because of its high morbidity and mortality. Cardiac embolism due to AF causes up to 25% of all ischaemic strokes underlining its supplement socio-economical relevance1. The prevalence of AF increases due to the rapidly growing proportion of elderly people. Apart from heart rate control and anticoagulation, transcatheter left atrial appendage (LAA) closure is a newly accepted therapeutic option in selected patients with permanent or paroxysmal AF who have contraindications for anticoagulation therapy and a high cardioembolic risk2,3.
Valvular heart disease, especially aortic valve stenosis (AVS), is ...
NEW ISSUE
Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …
February 19, 2021